253 related articles for article (PubMed ID: 29388264)
21. Silica nanoparticles: A promising platform for enhanced oral delivery of macromolecules.
Abeer MM; Rewatkar P; Qu Z; Talekar M; Kleitz F; Schmid R; Lindén M; Kumeria T; Popat A
J Control Release; 2020 Oct; 326():544-555. PubMed ID: 32687941
[TBL] [Abstract][Full Text] [Related]
22. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
Murugan B; Krishnan UM
Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
[TBL] [Abstract][Full Text] [Related]
23. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
Chen Y; Chen H; Shi J
Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
[TBL] [Abstract][Full Text] [Related]
24. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
[TBL] [Abstract][Full Text] [Related]
25. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
Chen Y; Chen H; Shi J
Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
[TBL] [Abstract][Full Text] [Related]
26. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment.
Rosenholm JM; Sahlgren C; Lindén M
Curr Drug Targets; 2011 Jul; 12(8):1166-86. PubMed ID: 21443474
[TBL] [Abstract][Full Text] [Related]
27. A smart upconversion-based mesoporous silica nanotheranostic system for synergetic chemo-/radio-/photodynamic therapy and simultaneous MR/UCL imaging.
Fan W; Shen B; Bu W; Chen F; He Q; Zhao K; Zhang S; Zhou L; Peng W; Xiao Q; Ni D; Liu J; Shi J
Biomaterials; 2014 Oct; 35(32):8992-9002. PubMed ID: 25103233
[TBL] [Abstract][Full Text] [Related]
28. Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.
Chakravarty R; Goel S; Hong H; Chen F; Valdovinos HF; Hernandez R; Barnhart TE; Cai W
Nanomedicine (Lond); 2015; 10(8):1233-46. PubMed ID: 25955122
[TBL] [Abstract][Full Text] [Related]
29. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.
Croissant JG; Fatieiev Y; Almalik A; Khashab NM
Adv Healthc Mater; 2018 Feb; 7(4):. PubMed ID: 29193848
[TBL] [Abstract][Full Text] [Related]
30. Mesoporous materials for drug delivery.
Vallet-Regí M; Balas F; Arcos D
Angew Chem Int Ed Engl; 2007; 46(40):7548-58. PubMed ID: 17854012
[TBL] [Abstract][Full Text] [Related]
31. Silica-based nanoprobes for biomedical imaging and theranostic applications.
Vivero-Escoto JL; Huxford-Phillips RC; Lin W
Chem Soc Rev; 2012 Apr; 41(7):2673-85. PubMed ID: 22234515
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in porous nanoparticles for drug delivery in antitumoral applications: inorganic nanoparticles and nanoscale metal-organic frameworks.
Baeza A; Ruiz-Molina D; Vallet-Regí M
Expert Opin Drug Deliv; 2017 Jun; 14(6):783-796. PubMed ID: 27575454
[TBL] [Abstract][Full Text] [Related]
33. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.
Baek S; Singh RK; Khanal D; Patel KD; Lee EJ; Leong KW; Chrzanowski W; Kim HW
Nanoscale; 2015 Sep; 7(34):14191-216. PubMed ID: 26260245
[TBL] [Abstract][Full Text] [Related]
34. Shape-mediated biological effects of mesoporous silica nanoparticles.
Hao N; Li L; Tang F
J Biomed Nanotechnol; 2014 Oct; 10(10):2508-38. PubMed ID: 25992407
[TBL] [Abstract][Full Text] [Related]
35. Biodegradation-tunable mesoporous silica nanorods for controlled drug delivery.
Park SB; Joo YH; Kim H; Ryu W; Park YI
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():64-73. PubMed ID: 25746247
[TBL] [Abstract][Full Text] [Related]
36. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
37. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer.
Li T; Shi S; Goel S; Shen X; Xie X; Chen Z; Zhang H; Li S; Qin X; Yang H; Wu C; Liu Y
Acta Biomater; 2019 Apr; 89():1-13. PubMed ID: 30797106
[TBL] [Abstract][Full Text] [Related]
38. Towards the Development of Smart 3D "gated scaffolds" for on-command delivery.
Mas N; Arcos D; Polo L; Aznar E; Sánchez-Salcedo S; Sancenón F; García A; Marcos MD; Baeza A; Vallet-Regí M; Martínez-Máñez R
Small; 2014 Dec; 10(23):4859-64. PubMed ID: 25079146
[TBL] [Abstract][Full Text] [Related]
39. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
40. Mesoporous silica nanoparticles as diagnostic and therapeutic tools: how can they combat bacterial infection?
Şen Karaman D; Manner S; Rosenholm JM
Ther Deliv; 2018 Mar; 9(4):241-244. PubMed ID: 29495945
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
